Back to Search VC Home Page
Venture Capital Search Engine
search over 1,000 Venture Capital related sites
Keywords about VC:  

Pfizer Strategic Investments Group

1.Frontenac Company - News   (53%):
Username Password DVC Group and Lake Capital Partner for Strategic and International Growth Frontenac Company Also to Invest Significant Equity Capital in Leading Marketing, Communications, and Technology Specialist November 6, 2000 CHICAGO, IL/ November 6, 2000/Businesswire/ -- Lake Capital, a Chic...
2.BioRen 8_15 release   (52%):
PFIZER ACQUIRES BIOREN For Immediate Release August 15 , 2005 NEW YORK, NY -- Pfizer Inc. and Bioren Inc. today announced the completion of a transaction in which Pfizer purchased all outstanding stock of Bioren for an undisclosed amount. Bioren is a California-based, privately held company special...
3.Axiom Ventures / Press Release   (46%):
January 6. 2004 FOR IMMEDIATE RELEASE Dr. George M. Milne, Jr. Joins Rib-X Pharmaceuticals Board Of Directors Former Pfizer Executive also to Serve as Consultant to this Antibiotic Development Company NEW HAVEN, Conn., Jan. 6 /PRNewswire/ -- Rib-X Pharmaceuticals, Inc., a privately held biotechnolo...
4.Harris & Harris Group Inc.   (44%):
NEWS RELEASE HARRIS & HARRIS GROUP, INC. DECEMBER 31, 2004 111 WEST 57TH STREET NEW YORK, NEW YORK 10019 NASDAQ/NMS SYMBOL: TINY CONTACT: CHARLES E. HARRIS TEL. NO. (212) 582-0900 HARRIS & HARRIS GROUP NOTES PFIZER APPROVAL TO MARKET LYRICA Harris & Harris Group, Inc., noted today that Pfizer In...
5.Conning Capital Partners: Press Release   (43%):
Press Release August 12, 2004 Conning Capital Invests In Evolution Benefits Funding Will Take Employee Benefits Technology Company to Profitability; $18.5 Million Round Included Sprout Group, Pfizer Inc. and founder, Robert Patricelli Hartford, Conn., August 12, 2004 - Conning Capital Partners ("Con...
6.BD Ventures   (39%):
About BD Contact BD Careers Products Investors Press Privacy Terms & Conditions Site Map Advanced Search BD - Worldwide Select a BD Location BD Ventures BD Ventures, L.L.C. operates a $40 million venture capital fund and is wholly-owned by BD. BD Ventures actively seeks early-stage investment op...
7.BD Ventures   (39%):
About BD Contact BD Careers Products Investors Press Privacy Terms & Conditions Site Map Advanced Search BD - Worldwide Select a BD Location BD Ventures BD Ventures, L.L.C. operates a $40 million venture capital fund and is wholly-owned by BD. BD Ventures actively seeks early-stage investment op...
8.Harris & Harris Group Inc.   (38%):
Press Releases 10/13/05 Article in Chemical & Engineering News 09/22/05 Continuum Photonics Merges with Polatis 09/21/05 Harris & Harris Group Invests Additional $2,500,000 in Molecular Imprints 09/20/05 Starfire Announces Strategic Alliance With Clariant 09/20/05 Harris & Harris Group Invests $960,...
9.Arboretum Ventures: News and Events   (34%):
Arboretum News | Related News | Events Asterand and Pharmagene to Merge Pharmagene plc, a London based company, announced its plans to merge with Asterand Inc. The combination of the two companies will create a global leader in human tissue services. Shares of the combined entity will trade on the L...
10.ChiraSource2001 Press Release   (34%):
The Catalyst Group Catalysts and Specialty Chemicals Fine Chemicals and Pharmaceuticals Polymers and Elastomers Combinatorial Chemistry Refining and Petrochemicals Chemicals Strategic Technology Consulting s Multi-Client Studies Membership Programs Conferences Key People Publications News/Press Rele...
11.Welcome to Academy Funds   (34%):
Academy Funds (Academy Ventures) is a family of venture capital funds focused on achieving outstanding investment returns in seed and early-stage companies. The following is a partial list of companies/institutions that have co-invested in and/or partnered with Academy portfolio companies: Advent V...
12.BioAdvance Ventures : News : Press Releases : April 22, 2005   (33%):
News TargetRx Announces $15 Million in Funding Led By Quaker BioVentures Pharmaceutical Marketing Information Company Continues Momentum Horsham, PA - April 22, 2005 - TargetRx, a marketing information services company that assists pharmaceutical companies in effectively selling and marketing their ...
13.Alta Partners: Our Team   (32%):
David joined Alta in 2002. David’s first Alta investment was Angiosyn (acquired by Pfizer in 2005) where he was Director and CEO. Prior to Alta, David co-founded and served as vice president of Genomics Research at Eos Biotechnology (acquired by Protein Design Labs in 2003). From 1995 to 1997...
14.New Document   (30%):
Reinaldo M. Diaz Reinaldo Diaz, who also serves on the Board of Directors of Berkeley Heart Labs, Inc., and advanced cardiovascular testing and e-healthcare company, has previously worked with a broad range of healthcare companies. His experience ranges from development stage companies to mature mul...
15.EuclidSR - Press Room   (29%):
back to news index Former Pfizer Executive Dr. George M. Milne, Jr. Joins Rib-X Pharmaceuticals Board Of Directors 01/06/2004 New Haven, CT - Rib-X Pharmaceuticals, Inc., a privately held biotechnology company developing the next generation of antibiotics, announced today that George M. Milne, Jr.,...
16.EuclidSR - Press Room   (29%):
back to news index Former Pfizer Executive Dr. George M. Milne, Jr. Joins Rib-X Pharmaceuticals Board Of Directors 01/06/2004 New Haven, CT - Rib-X Pharmaceuticals, Inc., a privately held biotechnology company developing the next generation of antibiotics, announced today that George M. Milne, Jr.,...
17.Commonwealth Associates   (29%):
Overview Investment Banking Services Recent Transactions Professionals News Careers Contact By becoming a strategic partner, Commonwealth enables the management team of each company, to focus on building their business, perpetuating growth and enhancing share holder value. Investment Professionals ...
18.New Document   (28%):
Frank R. Ruderman Frank Ruderman is the Chief Executive Officer, Chairman of the Board, and a Managing Partner of Tenex Greenhouse Ventures. Additionally, Mr. Ruderman is the Chairman and CEO of Berkeley HeartLab. He is also a founder of Tenex Medical Investors, an organization of angel investors wi...
19.Abingworth - News   (28%):
News Abingworth appoints leading UK biotech entrepreneurs Allan Marchington and Raj Parekh join as Entrepreneurs in Residence London, UK, 18 July 2003 - Abingworth Management, the international life science venture capital group, has appointed Drs Allan Marchington and Raj Parekh as Entrepreneurs in...
20.Columbia Strategy LLC   (28%):
Overview Management Team Executives-in- Residence Executives-in-Residence Greg Rorke For the past 20 years, Greg Rorke has been a senior manager for a number of emerging growth companies, special situations, corporate restructurings, and turnarounds. He began his career in the workout department of ...

Page: 1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20  

VC Directory: A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z   Others